Exercise Programs Lowered the Risk of Death for People With Cancer

CATEGORY: EXERCISE & MOVEMENT

People with cancer who were assigned to structured exercise programs were 26% less likely to die of any cause than patients who received usual care, in a pooled analysis of 13 randomized trials covering 3,282 people with breast, lung, blood and several other cancers.¹

Why Thirteen Trials Had to Be Read Together

Any single exercise trial in cancer patients faces a hard arithmetic problem: measuring survival takes years of follow-up and, thankfully, most trials record too few deaths for a clear answer on their own. The new review, published in Cancer Treatment Reviews, addressed that by pooling every eligible trial in which people with cancer were assigned by chance either to an exercise program or to usual care. That coin-flip assignment is what separates this evidence from the many studies that simply observe that active patients fare better—those can never rule out that patients well enough to exercise were healthier to begin with. Here, the exercise itself is the only planned difference between the groups.¹

From Brisk Walks to Dumbbells, Two Weeks to Three Years

The 13 trials enrolled 3,282 patients with a range of cancers, including breast, lung, blood, ovarian, esophageal and colorectal disease. The programs tested aerobic exercise—steady movement that raises the heart rate, as ordinary as a brisk walk or a bike ride—or resistance training—working the muscles against a load, like slowly curling a dumbbell up and letting it back down—or a combination of the two. Programs lasted anywhere from two weeks to three years, and the trials then tracked participants for up to ten years, counting deaths from any cause.¹

A Difference That Did Not Hinge on the Program’s Length

Pooled together, the trials showed a 26% lower risk of death among patients assigned to exercise, a result the reviewers rated as moderate-certainty evidence, with the individual trials landing notably close to one another. The reduction looked much the same whether programs were shorter or longer, and whether or not the cancer was a hormone-dependent type such as breast cancer—suggesting the benefit was not being driven by one kind of patient or one marathon-length program. The authors note that exercise may work through several routes at once, including effects on insulin (the hormone that controls blood sugar), inflammation and the immune system’s ongoing patrol for abnormal cells.¹

An 889-Patient Colon Cancer Trial Landed the Same Way

The pooled result sits on top of a growing stack of consistent evidence. In the largest single trial in this field, 889 colon cancer patients who had finished surgery and chemotherapy were assigned to a three-year coached exercise program or to health-education booklets; over roughly eight years, the exercisers were 37% less likely to die, with 90.3% still alive at eight years versus 83.2%.² And in observational data pooled from 151 patient groups—about 1.5 million people with cancer—those who stayed active after diagnosis had notably lower death rates—about 31% lower in breast cancer—though studies of that kind show association rather than cause.³

Key Takeaways

• Across 13 randomized trials of 3,282 people with cancer, structured exercise programs—aerobic, resistance, or both—cut the risk of death from any cause by 26% compared with usual care.
• Because exercise was assigned by chance, the pooled result carries causal weight that observational studies of active patients cannot.
• The benefit looked similar across shorter and longer programs and across cancer types studied, and it is consistent with the largest single trial, in which colon cancer patients in a coached program were 37% less likely to die over eight years.

References

1. Guillermou H, Diallo A, Rathat G, Galtier F. Physical activity reduces all-cause mortality in patients with cancer: a systematic review and meta-analysis of randomized controlled trials. Cancer Treatment Reviews. 2026;145:103122. link
2. Courneya KS, Vardy JL, O’Callaghan CJ, et al. Structured Exercise after Adjuvant Chemotherapy for Colon Cancer. New England Journal of Medicine. 2025;393(1):13–25. link
3. Ungvari Z, Fekete M, Varga P, et al. Exercise and survival benefit in cancer patients: evidence from a comprehensive meta-analysis. GeroScience. 2025;47(3):5235–5255. link